Contraception in the 21st century

A tétel rövid nézete
dc.contributor.advisorErdődi , Balázs
dc.contributor.advisordeptDebreceni Egyetem::Gyógyszerésztudományi Kar
dc.contributor.authorNgonthe Bekep, Ulrich Fleurin
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentKozma, Bence
dc.contributor.opponentBácskay, Ildikó
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Szülészeti és Nőgyógyászati Intézet
dc.contributor.opponentdeptDebreceni Egyetem::Gyógyszerésztudományi Kar::Gyógyszertechnológiai Tanszék
dc.date.accessioned2023-05-03T08:00:22Z
dc.date.available2023-05-03T08:00:22Z
dc.date.created2023-04-27
dc.description.abstractResearch on contraception has made steady progress in the last decade, which has improved the lives of women by lowering the number of unwanted births and other illnesses that significantly increased morbidity. Several nations have adopted family planning techniques including vaginal rings, transdermal patches, progestin injectables, and implants with one and two rods to space and reduce the birth rate. Other birth control techniques with a considerable incidence still include condoms and oral contraceptives with a new ethinylestradiol and nomegestrol combination. We have different conceptions of "contraceptives" depending on where we are on the planet. Data from the UN and the Demographic and Health Survey (DHS) revealed that the current prevalence in Europe and sub-Saharan Africa is 58.17% and 22%, respectively. In Europe, tablets and condoms are considered "common contraceptives" and are covered by reimbursement schemes. Due to funding from cooperation with various organizations or pharmaceutical manufacturers, injectables and implants appear to be the most widespread birth control methods in the sub-Saharan Africa region. Although the constant growth of contraceptives prevalence in both areas, vasectomy and tubal ligation, which ensure the lowest unintended pregnancy, are still not present among most couples. Some aspects like religion, culture, level of revenue, and even political agenda have been considered barriers to the best contraceptive prevalence. However, recent clinical trials have proven that males are at the center for the development of upcoming contraceptives like hormonal or non-hormonal gel.
dc.description.correctorLB
dc.description.coursegyógyszerész
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent37
dc.identifier.urihttps://hdl.handle.net/2437/351529
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectcontraception
dc.subjecthormone
dc.subject.dspaceDEENK Témalista::Orvostudomány
dc.titleContraception in the 21st century
Fájlok
Gyűjtemények
Theses (Faculty of Pharmacy)